Vireo Growth Inc. has announced its plan to acquire Bridgewell Agribusiness LLC, a supplier of organic and non‑GMO food and agricultural products. The move, detailed in a press release reported by Cannabis Business Times on May 26, 2026, values the transaction at an estimated closing purchase price of US$10,262,333.
Transaction Structure and Financial Details
The agreement sets a base purchase price of US$40 million. From this amount, Vireo Growth will assume roughly US$30 million of Bridgewell’s existing debt and cover certain transaction expenses, resulting in the net consideration of about US$10.26 million.
Consideration Mechanics
In exchange for Bridgewell’s membership interests, Vireo Growth will issue an unsecured, subordinated convertible note to the seller, BWAB Holdings LLC. The note’s principal equals the closing purchase price and is designed to automatically convert on or after the second anniversary of the closing date into an estimated 16,552,150 subordinate voting shares of Vireo.
The implied price for those shares is US$0.62 per share, a figure that will be determined by the volume‑weighted average trading price of Vireo’s subordinate voting shares over the 20 consecutive trading days ending two days before closing, in line with the policies of the Canadian Securities Exchange.
Regulatory and Securities Considerations
Closing the deal is subject to customary conditions, including the execution of definitive agreements and receipt of all required regulatory approvals, such as any needed clearance from the Canadian Securities Exchange.
Because the shares issued in the transaction are not registered under the U.S. Securities Act of 1933 or any state securities laws, they will be treated as “restricted securities” under Rule 144. Their offer or sale in the United States will therefore require an effective registration statement or an applicable exemption.
In Canada, the convertible note and the underlying shares will be distributed under applicable prospectus exemptions. They will be subject to a hold period of four months and one day from the date of distribution, as prescribed by National Instrument 45‑102 – Resale of Securities and related Canadian securities legislation.
Strategic Rationale and Market Context
Integrating Bridgewell’s organic and non‑GMO sourcing capabilities allows Vireo Growth to deepen its presence in the agricultural supply chain. Bridgewell functions as an intermediary that connects producers with food manufacturers while ensuring compliance with certification and regulatory standards.
Industry analysts note that publicly listed cannabis and hemp firms are increasingly pursuing vertical integration or diversification through acquisitions of agribusiness assets. By adding a certified organic supplier, Vireo Growth aims to strengthen its product offerings and potentially reduce reliance on third‑party ingredient providers.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Readers should consult a qualified healthcare professional before making any decisions related to health or medical conditions. Statements about the therapeutic uses of hemp, cannabis, or cannabinoid‑derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
For the original announcement, see the source: Here
